Development of research reagents specific for O-glcnac (O-glcnac lectenz)
Ended Definitive Contract Awarded Last action
- Contract number
- HHSN261201300048C
- Awardee
-
Lectenz Bio, Inc. UEI JTGCK219C6F4
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $999,970
Award facts
- Opportunity
-
- N44CO3101451 Solicitation number
- Contract value 100% obligated
- $999,970.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 5 offers Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Athens, GA 30602, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $999,970 |
About this award
This is a federal contract awarded by the National Cancer Institute, a component of the National Institutes of Health, to Glycosensors And Diagnostics, LLC, doing business as Lectenz Bio, a biotechnology company. The $999,970.00 cost-plus-fixed-fee contract is for the development of research reagents specific for O-GlcNAc (O-GlcNAc Lectenz). This builds on the company's prior federal grants to optimize and commercialize GlycoSense, a technology for monitoring glycoprotein glycosylation patterns, as well as develop engineered pan-specific reagents for N-glycan detection and enrichment, and novel reagents to monitor sulfation and fucose patterns in carbohydrates. The contract does not have a set-aside designation and is scheduled for completion on September 12, 2016.
Quick answers
Who was awarded contract HHSN261201300048C?
HHSN261201300048C was awarded to Lectenz Bio, Inc. by National Cancer Institute (National Institutes of Health) on September 13, 2013.
How much is contract HHSN261201300048C worth?
The government has obligated $999,970 on HHSN261201300048C.
Was contract HHSN261201300048C competed?
The extent of competition for HHSN261201300048C was full and open competition. The government received 5 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award